Margo A Brinton

age ~77

from Decatur, GA

Also known as:
  • Margo Brinton
  • Margo Bowen
  • Margo Park
  • Margo Owen
  • Margo Briton
  • Betty Park
Phone and address:
1646 Grove Park Ct, Decatur, GA 30033
4043151183

Margo Brinton Phones & Addresses

  • 1646 Grove Park Ct, Decatur, GA 30033 • 4043151183
  • Malvern, PA
  • Atlanta, GA
  • Danville, KY
  • Millis, MA
  • 1646 Grove Park Ct, Decatur, GA 30033 • 4042293889

Work

  • Position:
    Production Occupations

Education

  • Degree:
    Graduate or professional degree

Emails

Resumes

Margo Brinton Photo 1

Margo Brinton

view source

Us Patents

  • Methods And Compositions For Inhibition Of Viral Replication

    view source
  • US Patent:
    8303946, Nov 6, 2012
  • Filed:
    Sep 2, 2003
  • Appl. No.:
    10/654273
  • Inventors:
    Margo A. Brinton - Decatur GA, US
    Wei Li - Wayland MA, US
  • Assignee:
    Georgia State University Foundation, Inc. - Atlanta GA
  • International Classification:
    C12N 15/00
    C12N 15/33
    C12N 15/86
    C12Q 1/68
    C12Q 1/70
  • US Classification:
    424 931, 424 9321, 424 932, 435456, 435 5, 435 61
  • Abstract:
    The present invention is directed to methods and compositions that are effective in the inhibition of viral replication. In particular, the methods and compositions are effective at interfering with the activity of host cell proteins required in viral replication. For example, an embodiment of the invention is directed to inhibition of flavivirus replication wherein the replication is effected by changing the normal interactions of the host cell protein TIAR or TIA-1.
  • Compositions And Methods For Viral Resistance Genes

    view source
  • US Patent:
    20050244815, Nov 3, 2005
  • Filed:
    Dec 15, 2004
  • Appl. No.:
    11/012762
  • Inventors:
    Margo Brinton - Decatur GA, US
    Andrey Perelygin - Alpharetta GA, US
  • Assignee:
    Georgia State University Research Foundation - Atlanta GA
  • International Classification:
    C12Q001/70
    C12Q001/68
  • US Classification:
    435005000, 435006000
  • Abstract:
    The present invention is directed to methods and compositions for identifying viral resistance genes and for identifying individuals having resistant or susceptible genotypes. Once identified as either resistant or susceptible, appropriate actions, such as vaccination, can be undertaken by the individuals. In particular, methods and compositions for identifying genes associated with resistance or susceptibility for flaviviruses are disclosed.
  • Compositions And Methods For Viral Resistance Genes

    view source
  • US Patent:
    20070269828, Nov 22, 2007
  • Filed:
    Apr 25, 2007
  • Appl. No.:
    11/789687
  • Inventors:
    Margo Brinton - Decatur GA, US
    Andrey Perelygin - Alpharetta GA, US
  • International Classification:
    C12Q 1/68
  • US Classification:
    435006000
  • Abstract:
    The present invention further provides a method of evaluating yellow fever virus susceptibility in a subject, which comprises obtaining a nucleic acid containing at least a portion of OAS gene from the subject, and determining whether the nucleic acid comprises SNPs relating to the susceptibility of the subject to yellow fever virus-associated condition. Also provided is a method of evaluating tick-borne encephalitis virus susceptibility in a subject, which comprises obtaining a nucleic acid containing at least a portion of OAS gene from the subject, and whether the nucleic acid comprises SNPs relating to the susceptibility of the subject to tick-borne encephalitis virus-associated condition.
  • Methods And Compositions For Inhibition Of Viral Replication

    view source
  • US Patent:
    20090186842, Jul 23, 2009
  • Filed:
    Jul 16, 2007
  • Appl. No.:
    11/879493
  • Inventors:
    Margo A. Brinton - Decatur GA, US
    Mohamed M. Emara - Atlanta GA, US
  • International Classification:
    A61K 31/7105
    C12N 7/01
    C12N 5/06
    A61P 31/12
  • US Classification:
    514 44, 4352351, 435325
  • Abstract:
    The present invention is directed to methods and compositions that are effective in the inhibition of viral replication. In particular, the methods and compositions are effective at interfering with the activity of host cell proteins required in viral replication. For example, an embodiment of the invention is directed to methods and compositions comprising RNA sequences to which the host cell proteins TIAR and/or TIA-1 bind.
  • Methods And Compositions For Inhibition Of Viral Replication

    view source
  • US Patent:
    20100166704, Jul 1, 2010
  • Filed:
    Apr 7, 2008
  • Appl. No.:
    12/082095
  • Inventors:
    Margo A. Brinton - Decatur GA, US
    Mohamed M. Emara - Roswell GA, US
    Wei Li - Wayland MA, US
  • International Classification:
    A61K 38/21
    A61K 39/395
    A61K 35/76
    A61K 38/00
    A61K 38/16
    A61K 31/7088
  • US Classification:
    424 854, 4241301, 424 936, 514 2, 514 12, 514 44 R
  • Abstract:
    The present invention is directed to methods and compositions that are effective in the inhibition of viral replication. In particular, the methods and compositions are effective at interfering with the activity of host cell proteins required in viral replication. For example, an embodiment of the invention is directed to inhibition of flavivirus replication wherein the replication is affected by changing the normal interactions of the host cell protein TIAR or TIA-1.
  • Dna Sequence Encoding A Cynomolgus Monkey Hepatitis A Virus Capsid Protein

    view source
  • US Patent:
    54301351, Jul 4, 1995
  • Filed:
    Jul 6, 1993
  • Appl. No.:
    8/087016
  • Inventors:
    Omana V. Nainan - Decatur GA
    Harold S. Margolis - Lilburn GA
    Betty H. Robertson - Chamblee GA
    Margo A. Brinton - Atlanta GA
    James W. Ebert - Lilburn GA
  • Assignee:
    The United States of America as represented by the Department of Health
    and Human Services - Washington DC
  • International Classification:
    C07H 1700
    C12P 2102
    C12P 1934
    C12N 1500
  • US Classification:
    536 2372
  • Abstract:
    The present invention relates, in general, to substantially pure preparations of the cynomolgus monkey hepatitis A viral isolates CY-145 and CY-55/JM-55; cDNAs of the genomic RNAs of cynomolgus monkey hepatitis A viral isolates CY-145 and CY-55/JM-55; a method of preventing hepatitis A in an animal; and vaccines comprising the cynomolgus monkey hepatitis A viral isolates CY-145 and CY-55/JM-55.

Isbn (Books And Publications)

Viral Pathogenesis and Immunity

view source

Author
Margo A. Brinton

ISBN #
0123694647

Positive Strand Rna Viruses

view source

Author
Margo A. Brinton

ISBN #
0387825223

Viral Pathogenesis and Immunity

view source

Author
Margo A. Brinton

ISBN #
0781711037

Positive Strand RNA Viruses: Proceedings of a UCLA Symposium Held in Keystone, Colorado, April 20-26, 1986

view source

Author
Margo A. Brinton

ISBN #
0845126539

Positive Strand Rna Viruses

view source

Author
Margo A. Brinton

ISBN #
3211825223


Get Report for Margo A Brinton from Decatur, GA, age ~77
Control profile